CASP4 and non-small cell lung carcinoma: According to the Log-rank Mantel-Cox and Gehan-Breslow-Wilcoxon test, the survival rate of NSCLC patients who had higher expression of tumor-associated caspase-4 was significantly lower (p < 0.0001) than those who had lower levels (Table 6).